According to the most recent data from the National Cancer Center, venous
thromboembolism (VTE) has unsurprisingly become one of the most common complications …

Management of cancer-associated venous thromboembolism (VTE) is essential in treatment
selection and cancer prognosis. However, to date, there is no method to assess the risk of …

Background Venous thromboembolism (VTE) increases the risk of death or adverse
outcomes in patients with lung cancer. Therefore, early identification and treatment of high …

Epidemiology and risk factors for venous thromboembolism in... : Current Opinion in Oncology
Epidemiology and risk factors for venous thromboembolism in lung cancer : Current Opinion …

Background Patients with lung cancer are known to be at increased risk for venous
thromboembolism (VTE). Venous thromboembolism is associated with increased risk for …

This study aimed to develop and validate a risk score for early prediction of venous
thromboembolism (VTE) in patients with lung cancer. A total of 827 patients with lung cancer …

Introduction The risk of venous thromboembolism (VTE) varies among tumour types, and
different cancer type-specific risks for VTE prediction remain undefined. We aimed to …

Simple Summary The predictive value of existing venous thromboembolism risk assessment
models (RAMs) in lung cancer patients is still debated, and the design of new models …

Introduction Venous thromboembolism (VTE) is a common complication in patients with
cancer and has a determining role in the disease prognosis. The risk is significantly …

Background: Several biomarkers or risk factors have been identified and several prediction
models exist. The major limitations inherent in these models include cost-ineffectiveness …